CurrentRheuma
Get Weekly

Topic · page 4 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 121–160 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. Arthritis Res Ther

    TPI1 and TPM4 are strong candidate RNA biomarkers for systemic sclerosis

    Diagnostic or prognostic study

  2. Arthritis Rheumatol

    Drug‐Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database

    Cohort study

  3. J Rheumatol

    Comparing Novel and Legacy Health Assessment Questionnaire Scoring Methods: A Scleroderma Patient-centered Intervention Network Cohort Study

    Cohort study

  4. J Rheumatol

    Factor Analysis to Determine Subgroups of Gastrointestinal Symptoms in Systemic Sclerosis

    Cross-sectional study

  5. Clin Exp Rheumatol

    Nailfold capillaroscopy by dermatoscope in systemic sclerosis: a systematic review and meta-analysis

    Meta-analysis

  6. Arthritis Res Ther

    IL-35 enhances IL-10⁺ breg-mediated immunoregulation and attenuates inflammation and fibrosis in systemic sclerosis

    Mechanistic study

  7. Rheumatology (Oxford)

    Risk stratifying systemic sclerosis–related pulmonary hypertension by left atrial strain

    Cohort study

  8. Joint Bone Spine

    High-dose chemotherapy and transplantation of autologous CD34+ selected stem cells for progressive systemic sclerosis adjusted to cardiac and lung manifestation: An open-label, non-inferiority phase 2 trial

    Cohort study

  9. Arthritis Care Res (Hoboken)

    Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease

    Research article

  10. Rheumatology (Oxford)

    Evaluation of a screening algorithm to detect systemic sclerosis-related myopathy

    Cohort study

  11. Rheumatology (Oxford)

    Development of a tool to map SSc pain sources, characteristics and management experiences: the SPIN Pain Assessment Tool

    Research article

  12. Arthritis Care Res (Hoboken)

    Systemic Sclerosis–Associated Myopathy in a Large Single‐Center Cohort: Autoantibody Profiles, Histologic Features, and Independent Risk of Death

    Cohort study

  13. Ann Rheum Dis

    The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

    Cohort study

  14. Arthritis Res Ther

    Soluble CD13 in systemic sclerosis: clinical observations and transcriptomic insights from peripheral blood

    Cross-sectional study

  15. Rheumatology (Oxford)

    Clinical predictors of mortality in critically ill systemic sclerosis patients: a 6-year retrospective cohort study

    Cohort study

  16. RMD Open

    Mesenchymal stromal cells ameliorate systemic sclerosis-interstitial lung disease via PD-1/PD-L1 signalling axis

    Mechanistic study

  17. Clin Exp Rheumatol

    Phosphodiesterase-5 inhibitors, but not calcium channel blockers, improve peripheral vascular function in systemic sclerosis

    Cross-sectional study

  18. Clin Exp Rheumatol

    Clinical characteristics, predictors and prognosis of systemic sclerosis with scleroderma renal crisis and pulmonary arterial hypertension

    Cohort study

  19. Arthritis Rheumatol

    Identification of Risk Factors for Incident Left Ventricular Systolic Dysfunction and Predictors of Cardiac Recovery in Patients With Systemic Sclerosis

    Cohort study

  20. Arthritis Rheumatol

    Telomere Length of Peripheral Blood Leukocytes Predicts Disease Severity and Worse Survival in Systemic Sclerosis

    Cohort study

  21. Ann Rheum Dis

    Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease

    Mechanistic study

  22. Clin Exp Rheumatol

    Lung cancer risk in systemic sclerosis: data from an inception cohort and meta-analysis of published studies

    Meta-analysis

  23. Arthritis Care Res (Hoboken)

    Assessment of Skin in Patients With Systemic Sclerosis Using High‐Frequency Ultrasound and Shear Wave Elastography: A Comparative Study With Histology, Molecular, and Clinical Parameters

    Diagnostic or prognostic study

  24. Semin Arthritis Rheum

    Hand function impairment in Systemic Sclerosis: determinants through investigations of clinical, radiographic and ultrasonographic features

    Cross-sectional study

  25. Rheumatology (Oxford)

    Work participation and work disability in Belgian patients with systemic sclerosis

    Cross-sectional study

  26. Clin Exp Rheumatol

    Prevention and management of gastrointestinal side effects in patients with systemic sclerosis-interstitial lung disease receiving anti-fibrotic therapy: a modified Delphi consensus study

    Guideline or statement

  27. Ann Rheum Dis

    Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multiomics analysis

    Mechanistic study

  28. Rheumatology (Oxford)

    Gut microbiome–metabolome dysregulation in systemic sclerosis: a multi-omics study

    Case-control study

  29. Rheumatology (Oxford)

    Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry

    Cross-sectional study

  30. Arthritis Res Ther

    Clinical significance of inflammation-coagulation-autoantibody triad in systemic sclerosis-associated interstitial lung disease: a retrospective study

    Cohort study

  31. Semin Arthritis Rheum

    Benefits of nintedanib continuation in systemic autoimmune rheumatic disease-related progressive pulmonary fibrosis: KEIO-SARD-ILD-cohort

    Cohort study

  32. RMD Open

    Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo study

    Mechanistic study

  33. Ann Rheum Dis

    RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis

    Mechanistic study

  34. Arthritis Res Ther

    A composite biomarker score to predict modified Rodnan skin score in systemic sclerosis: insight from autologous stem cell transplantation international scleroderma trial

    Secondary analysis

  35. Arthritis Care Res (Hoboken)

    The Effect of Pulmonary Function Test Reference Equations on Classification of Restrictive Lung Disease Severity in Systemic Sclerosis

    Cohort study

  36. Rheumatology (Oxford)

    Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in SSc: a real-world national cohort study

    Cohort study

  37. Arthritis Care Res (Hoboken)

    International Investigation of the Gut‐Lung Axis in Systemic Sclerosis–Interstitial Lung Disease

    Cross-sectional study

  38. Clin Exp Rheumatol

    Clinical distinctions of anti-topoisomerase positive limited cutaneous systemic sclerosis in early disease: results from the early Systemic sclerOsis Longitudinal Assessment Registry from Turkey

    Cross-sectional study

  39. Rheumatology (Oxford)

    Association of onset age with features of patients with systemic sclerosis in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC)

    Cohort study

  40. Arthritis Rheumatol

    Skin Biopsies Enhance Prediction of Clinical Trajectory in Diffuse Cutaneous Systemic Sclerosis

    Secondary analysis

All 671 Briefs in ExploreShowing Briefs 121–160 of 671, newest first